Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A new era for anticoagulation in atrial fibrillation.

× No keyword cloud information.

26 in total

Review 1. Opportunities for cost reduction of medical care: part 3.

Authors: Monte Malach; William J Baumol
Journal: J Community Health Date: 2012-08

2. Hotline update of clinical trials and registries presented at the at the European Society of Cardiology Congress in Paris 2011.

Authors: K Walenta; J M Sinning; C Werner; M Böhm
Journal: Clin Res Cardiol Date: 2011-09-30 Impact factor: 5.460

3. Safety of warfarin therapy in chronic hemodialysis patients: a prospective cohort study.

Authors: Matsuhiko Hayashi; Takayuki Abe; Mieko Iwai; Ayumi Matsui; Tadashi Yoshida; Yuji Sato; Yoshihiko Kanno
Journal: Clin Exp Nephrol Date: 2015-12-01 Impact factor: 2.801

Review 4. [Anticoagulant therapy for chronic cardiac diseases. Atrial fibrillation, valvular heart disease, congestive heart failure].

Authors: B Witzenbichler
Journal: Internist (Berl) Date: 2011-11 Impact factor: 0.743

5. Comparison of Safety Profiles of New Oral Anticoagulants with Warfarin Using the Japanese Spontaneous Reporting Database.

Authors: Keiko Hosohata; Saki Oyama; Iku Niinomi; Tomohito Wakabayashi; Ayaka Inada; Kazunori Iwanaga
Journal: Clin Drug Investig Date: 2019-07 Impact factor: 2.859

Review 6. Clinical considerations of anticoagulation therapy for patients with atrial fibrillation.

Authors: Shu Zhang
Journal: J Zhejiang Univ Sci B Date: 2012-08 Impact factor: 3.066

7. Erratum: utilization of anticoagulation therapy in medicare patients with nonvalvular atrial fibrillation.

Authors: Kate Fitch; Jonah Broulette; Bruce Pyenson; Kosuke Iwasaki; Winghan Jacqueline Kwong
Journal: Am Health Drug Benefits Date: 2012-05

8. Clinical characteristics and outcomes of dialysis patients with atrial fibrillation: the Fushimi AF Registry.

Authors: Yugo Yamashita; Daisuke Takagi; Yasuhiro Hamatani; Moritake Iguchi; Nobutoyo Masunaga; Masahiro Esato; Yeong-Hwa Chun; Hitoshi Itoh; Masato Nishimura; Hiromichi Wada; Koji Hasegawa; Hisashi Ogawa; Mitsuru Abe; Masaharu Akao
Journal: Heart Vessels Date: 2016-03-14 Impact factor: 2.037

Review 9. Apixaban: a review of its use for reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

Authors: Gillian M Keating
Journal: Drugs Date: 2013-06 Impact factor: 9.546

Review 10. Rivaroxaban: a review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation.

Authors: Natalie J Carter; Greg L Plosker
Journal: Drugs Date: 2013-05 Impact factor: 9.546